(WOIO) - Seven Ohio oncologists have been ordered to collectively pay nearly $2.6 million after pleading guilty to importing cancer medications that had not been approved by the FDA.
The doctors pleaded guilty to causing the shipment of misbranded drugs, a misdemeanor violation of the Food, Drug and Cosmetic Act. They were sentenced to probation and ordered to pay fines and restitution.
Their names, ages, the city where they practiced medicine and the amount they were ordered to pay:
- Ranjan Bhandari, 56, Liverpool, $1,139,532.
- Timmappa Bidari, 68, Parma, $158,418.
- David Fishman, 62, Euclid, $150,000.
- Su-Chiao Kuo, 60, Brunswick, $179,840.
- Marwan Massouh, 54, Westlake, $609,150.
- Poornanand Palaparty, 62, Cleveland, $128,160.
- Hassan Tahsildar, 55, Euclid, $179,316.
The doctors are accused of obtaining drugs, including Zometa, Kytril, Taxotere, Gemzar, Eloxatin and others, from outside the United States, where the drugs were not approved by the FDA, according to the charges.
A drug may be considered misbranded even if it is identical in composition to an FDA-approved drug (that is, a drug labeled and packaged in compliance with the FDA's standards) and even if it was made by the same manufacturer in the same facility as the FDA-approved version.